The tyrosine kinase Lyn limits the cytokine responsiveness of plasma cells to restrict their accumulation in mice

Simona Infantino, Sarah A Jones, Jennifer A Walker, Mhairi Jane Maxwell, Amanda Light, Kristy O'Donnell, Evelyn Tsantikos, Victor Peperzak, Toby James Phesse, Matthias R Ernst, Fabienne Mackay-Fisson, Margaret Hibbs, Kirsten Fairfax, David M Tarlinton

Research output: Contribution to journalArticleResearchpeer-review

11 Citations (Scopus)


Maintenance of an appropriate number of plasma cells, long-lived antibody-producing cells that are derived from B cells, is essential for maintaining immunological memory while limiting disease. Plasma cell survival relies on extrinsic factors, the limited availability of which determines the size of the plasma cell population. Mice deficient in the nonreceptor tyrosine kinase Lyn are prone to an autoimmune disease that is characterized by inflammation and an excess of plasma cells (plasmacytosis). We demonstrated that the plasmacytosis was intrinsic to B cells and independent of inflammation. We also showed that Lyn attenuated signaling by signal transducer and activator of transcription 3 (STAT3) and STAT5 in response to the cytokines interleukin-6 (IL-6) and IL-3, respectively, in two previously uncharacterized plasma cell signaling pathways. Thus, in the absence of Lyn, the survival of plasma cells was improved, which enabled the plasma cells to become established in excess numbers in niches in vivo. These data identify Lyn as a key regulator of survival signaling in plasma cells, limiting plasma cell accumulation and autoimmune disease susceptibility.
Original languageEnglish
Pages (from-to)1 - 10
Number of pages10
JournalScience Signaling
Issue number338
Publication statusPublished - 2014

Cite this